Grass pollen Allergy Immunotherapy Tablet regulatory update

ALK-Abello said FDA's Allergenic Products Advisory Committee will meet on Nov. 6 to discuss a BLA from partner Merck for grass Allergy Immunotherapy Tablet (AIT). Merck said it expects a decision on t...